Diabetes, Digestive, and Kidney Diseases Extramural Research in Louisiana
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $65.5 million to recipients in Louisiana in 63 grants from fiscal 2021 to 2025, 0.7% of the program's national total. Pennington Biomedical Research Center received the most, $34.1 million.
- Awarded in Louisiana$65.5 million
- Awards63
- Share of the program0.7%
- Rank among states26th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 29 | $12.4 million |
| FY 2022 | 29 | $12.0 million |
| FY 2023 | 32 | $13.3 million |
| FY 2024 | 35 | $13.1 million |
| FY 2025 | 33 | $14.8 million |
Recipients in Louisiana
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Pennington Biomedical Research Center | Colleges and universities | 33 | $34.1 million |
| The Administrators of Tulane Educational Fund | Colleges and universities | 23 | $26.8 million |
| Louisiana State University | Colleges and universities | 5 | $3.6 million |
| Louisiana State University | Colleges and universities | 2 | $1.2 million |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Louisiana?
$65.5 million from fiscal 2021 to 2025, across 63 awards. Louisiana ranks 26th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Louisiana?
The largest recipient is Pennington Biomedical Research Center, with $34.1 million in 33 awards. Next are The Administrators of Tulane Educational Fund and Louisiana State University.
Can organizations in Louisiana apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Louisiana
- Grants to States for Medicaid
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Highway Planning and Construction
- Education Stabilization Fund
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Child Care and Development Block Grant
- Broadband Equity, Access, and Deployment Program